ALFA Finder
13:29 IST
BSE
Other Announcement
Vivanza Biosciences Other Announcement
Vivanza Biosciences Ltd has filed a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2026.
Vivanza Biosciences Ltd
- Share price
- ₹1.47
- Market cap
- ₹5.88 Cr
- Revenue (annual)
- ₹115.9 Cr
- Net profit (annual)
- ₹0.39 Cr
- P/E (TTM)
- 213.0×Sector 43.8×
- Promoter holding
- 20.02%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Board Meeting Date 4Other Announcement 2Financial Results 2Management Change 1Business Update 1Board Meeting Outcome 1Annual Report 1Annual General Meeting 1
Time
2 announcements with these filters
10:33 IST
BSE
Other Announcement
Vivanza Biosciences Other Announcement
Vivanza Biosciences declared that its statutory auditors issued an audit report with an unmodified opinion. This covers results for the quarter and year ended March 31, 2026.